Tech Company Financing Transactions
Laronde Funding Round
Laronde closed a $50 million funding round on 5/11/2021. Investors included Flagship Pioneering.
Transaction Overview
Company Name
Announced On
5/11/2021
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Flagship Pioneering (Noubar Afeyan)
Proceeds Purpose
The capital will support the development of Laronde's platform and initial pipeline of new medicines.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
55 Cambridge Pkwy. 800E
Cambridge, MA 02142
USA
Cambridge, MA 02142
USA
Phone
Undisclosed
Website
Email Address
Overview
Laronde is building a company fueled by our modular Endless RNA (eRNA) platform, which will be supported by a large-scale digital and manufacturing infrastructure with the bold vision of 100 new medicines within the next decade. With eRNA, we're making new therapeutics that will become essential medicines of the future.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Diego Miralles
Chief Operating Officer
Tej Pavoor
Chief Scientific Officer
Jesper Gromada
Chief Technical Officer
Vadim Dudkin
VP - R & D
Jennifer Nelson
Browse more venture capital transactions:
Prev: 5/10/2021: Figure venture capital transaction
Next: 5/11/2021: Cycode venture capital transaction
Share this article
News on VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs